Conclusion of non-exclusive discount agreements pursuant to §130a para. 8 SGB V for various active ingredients/combinations with the possibility of conclusion at any time within the scope of the so-called Open House procedure
Abschluss nicht-exklusiver Rabattvereinbarungen nach §130a Abs.8 SGB V zu verschiedenen Wirkstoff-/en/-kombinationen mit jederzeitiger Abschlussmöglichkeit im Rahmen des sog. Open House-Verfahrens
Germany · Potsdam · how to bid here →
Your path to submission
- Deadline: 5 March at 00:00 — 537 days left.
- The submission point is stated in the notice (link on the right).
- Offer and evidence in: DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU.
- Collect your evidence — use the eligibility analysis above: it lists the requirements and, for known certificates, how to get them.
Clement What the numbers say about this buyer
- In this sector the buyer awards roughly every 2 months (20 awards, most recently August 2021) — by that rhythm the next award was due around October 2021. The last award went to Bayer Vital GmbH.n = 20
- 24% of this buyer's awards went to companies that had already won here before (59 awards since 2018, spread over 45 companies). That is well below the sector norm (62%) — this buyer switches suppliers more often than others.n = 59 awards since 2018
- The median procedure drew 2 bids (59 procedures with a bid count); 47% ended with a single bidder. Sector: median 2 bids.n = 59
- Across 41 procedures with structured selection criteria, this buyer most often required: Staff qualifications (40 of 41), Trade register enrolment (38 of 41), Security of supply required (1 of 41), Professional liability insurance (1 of 41).n = 41
- Not one of the 59 awards with a known winner country has gone to a foreign company so far. Sector average: 1%.n = 59
From this buyer's documented awards; comparison values from the same sector and country. Not a forecast, not legal advice. As of 13/09/2026.
Foreign bidders
In Germany · Medical equipment & pharma, 257 contracts went to foreign companies over the last 3 years (of 21,997 recorded awards) — mostly from Austria, Netherlands, France.
Typical field: median 19 (from 387 awards).
What the buyer is looking for
Gegenstand dieser Veröffentlichung ist der Abschluss von Vereinbarungen nach § 130a Abs.8 SGB V zu verschiedenen Wirkstoffen/Wirkstoffkombinationen im Rahmen eines sogenannten Open House-Verfahrens.
What you must prove — eligibility criteria
Contract
Who has won here before
| Company | Awards | Period |
|---|---|---|
| Hexal AG · Holzkirchen | 21 | 2013–2016 |
| ratiopharm GmbH | 17 | 2013–2016 |
| Aliud Pharma GmbH · Laichingen | 15 | 2013–2016 |
| STADAPHARM GmbH · Bad Vilbel | 13 | 2014–2016 |
| TAD Pharma GmbH · Cuxhaven | 12 | 2013–2016 |
How often this buyer tenders this
Who knows the rhythm prepares instead of reacting.
How to bid
Guide: how to apply on cosinex Vergabemarktplatz / DTVP → Registration, signature, fees — from the operator's bidder manual.